Drug General Information
Drug ID
D0M1YO
Former ID
DNC000556
Drug Name
Dideoxycytidine
Drug Type
Small molecular drug
Indication Discovery agent Phase 2 [521414]
Structure
Download
2D MOL

3D MOL

Formula
C9H13N3O3
Canonical SMILES
C1CC(OC1CO)N2C=CC(=NC2=O)N
InChI
1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1
InChIKey
WREGKURFCTUGRC-POYBYMJQSA-N
CAS Number
CAS 107-95-9
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:16958
Target and Pathway
Target(s) HIV-1 reverse transcriptase Target Info Inhibitor [537934]
References
Ref 521414ClinicalTrials.gov (NCT00000678) Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.. U.S. National Institutes of Health.
Ref 537934Current use of anti-HIV drugs in AIDS. J Antimicrob Chemother. 1993 Jul;32 Suppl A:133-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.